InvestorsHub Logo
Followers 35
Posts 5775
Boards Moderated 0
Alias Born 02/20/2015

Re: None

Friday, 02/23/2018 12:41:36 PM

Friday, February 23, 2018 12:41:36 PM

Post# of 50157
Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology

The study authors further concluded that “results clearly demonstrate that PHP Therapy appears to be an effective means of obtaining rapid intrahepatic disease control, and is a sensible option in patients with predominant liver disease.” Researchers said their results support the use of PHP Therapy in an integrated approach to the management of metastatic ocular melanoma, and looked to the company’s Phase 3 FOCUS Trial to further quantify the benefit and optimize treatment strategies for these patients.

https://www.otcmarkets.com/stock/DCTH/news/Positive-Results-From-a-Multi-Center-Analysis-of-Delcath-PHP-Therapy-Published-in-Journal-of-Surgical-Oncology?id=179899
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News